Literature DB >> 2449461

Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients.

A Melms1, B C Schalke, T Kirchner, H K Müller-Hermelink, E Albert, H Wekerle.   

Abstract

The thymus is believed to play a central role in the pathogenesis of Myasthenia gravis (MG). According to a previous hypothesis, MG is initiated within the thymus by immunogenic presentation of locally produced nicotinic acetylcholine receptor (AChR) to potentially autoimmune T cells. Data of 10 consecutive MG patients demonstrate two critical features of MG thymuses that support the concept of intrathymic activation of autoreactive, AChR-specific lymphocytes. Morphologically, the thymuses showed lympho-follicular hyperplasia in nine cases and benign thymoma in one case. The paramount feature revealed by immunohistological double marker analyses was the intimate association of myoid cells (antigen producing) with interdigitating reticulum cells (potentially antigen presenting cells), both of which were surrounded by T3+ lymphocytes in thymus medulla. All 10 thymuses contained T lymphocytes reactive with AChR. This was in contrast to the peripheral immune compartment (blood) where in only 3 of 10 patients, significant T cell responses to AChR were observed. AChR-specific T cell lines could be established from 8 of 10 thymuses, all members of the helper/inducer subset as indicated by the expression of markers T3 and T4.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449461      PMCID: PMC442543          DOI: 10.1172/JCI113401

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis.

Authors:  O Abramsky; A Aharonov; C Webb; S Fuchs
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

2.  Interdigitating reticulum cells in the human thymus.

Authors:  E Kaiserling; H Stein; H K Müller-Hermelink
Journal:  Cell Tissue Res       Date:  1974       Impact factor: 5.249

3.  A histologic reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy.

Authors:  L I Alpert; A Papatestas; A Kark; R S Osserman; K Osserman
Journal:  Arch Pathol       Date:  1971-01

4.  Microenvironments in the normal thymus and the thymus in myasthenia gravis.

Authors:  M Bofill; G Janossy; N Willcox; M Chilosi; L K Trejdosiewicz; J Newsom-Davis
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

5.  Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis.

Authors:  I Kao; D B Drachman
Journal:  Science       Date:  1977-01-07       Impact factor: 47.728

6.  Antigen presentation: comments on its regulation and mechanism.

Authors:  E R Unanue; D I Beller; C Y Lu; P M Allen
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

7.  Thymic myogenesis, T-lymphocytes and the pathogenesis of myasthenia gravis.

Authors:  H Wekerle; R Hohlfeld; U P Ketelsen; J R Kalden; I Kalies
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

8.  Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis.

Authors:  D B Drachman; R N Adams; L F Josifek; S G Self
Journal:  N Engl J Med       Date:  1982-09-23       Impact factor: 91.245

9.  A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis.

Authors:  C W Olanow; A S Wechsler; A D Roses
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

10.  Acetylcholine receptor antibody-producing cells in thymus and lymph nodes in myasthenia gravis.

Authors:  Y Fujii; Y Monden; J Hashimoto; K Nakahara; Y Kawashima
Journal:  Clin Immunol Immunopathol       Date:  1985-01
View more
  31 in total

Review 1.  Intrathymic expression of neuromuscular acetylcholine receptors and the immunpathogenesis of myasthenia gravis.

Authors:  Arnold I Levinson; Yi Zheng; Glen Gaulton; Decheng Song; Jonni Moore; C Hank Pletcher
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia.

Authors:  Rozen Le Panse; Géraldine Cizeron-Clairac; Jacky Bismuth; Sonia Berrih-Aknin
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

3.  Autoimmune disease and the nervous system.

Authors:  L Steinman
Journal:  West J Med       Date:  1992-06

4.  Single-nucleotide polymorphisms in the B7H3 gene are not associated with human autoimmune myasthenia gravis.

Authors:  Priya Sakthivel; Xiongbiao Wang; Baback Gharizadeh; Ricardo Giscombe; Ritva Pirskanen; Pål Nyren; Ann Kari Lefvert
Journal:  J Genet       Date:  2006-12       Impact factor: 1.166

5.  Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy.

Authors:  J B Kuks; P C Limburg; H J Oosterhuis; T H The
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

6.  Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

Authors:  N Sommer; B Sigg; A Melms; M Weller; K Schepelmann; V Herzau; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

7.  Phenotypic and functional characterization of T cells from patients with myasthenia gravis.

Authors:  F Mokhtarian; M Pino; W Ofosu-Appiah; D Grob
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 8.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

9.  T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the gamma and delta subunits.

Authors:  A A Manfredi; M P Protti; M W Dalton; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.

Authors:  Florence Jambou; Wei Zhang; Monique Menestrier; Isabelle Klingel-Schmitt; Olivier Michel; Sophie Caillat-Zucman; Abderrahim Aissaoui; Ludovic Landemarre; Sonia Berrih-Aknin; Sylvia Cohen-Kaminsky
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.